<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Paediatr Child Health</journal-id>
<journal-id journal-id-type="iso-abbrev">Paediatr Child Health</journal-id>
<journal-id journal-id-type="publisher-id">pch</journal-id>
<journal-title-group>
<journal-title>Paediatrics &amp; Child Health</journal-title>
</journal-title-group>
<issn pub-type="ppub">1205-7088</issn>
<issn pub-type="epub">1918-1485</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>US</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30919832</article-id>
<article-id pub-id-type="pmc">6234423</article-id>
<article-id pub-id-type="doi">10.1093/pch/pxy093</article-id>
<article-id pub-id-type="publisher-id">pxy093</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Position Statements / Documents de Principes</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of the child with global developmental delay and intellectual disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bélanger</surname>
<given-names>Stacey A</given-names>
</name>
<xref ref-type="aff" rid="AF0001"></xref>
<xref ref-type="corresp" rid="c1"></xref>
<!--<email>info@cps.ca</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caron</surname>
<given-names>Joannie</given-names>
</name>
<xref ref-type="aff" rid="AF0001"></xref>
<xref ref-type="corresp" rid="c1"></xref>
<!--<email>info@cps.ca</email>-->
</contrib>
</contrib-group>
<aff id="AF0001">Canadian Paediatric Society, Mental Health and Developmental Disabilities Committee, Ottawa, Ontario</aff>
<author-notes>
<corresp id="c1"><bold>Correspondence:</bold> Canadian Paediatric Society, 100–2305 St. Laurent Blvd., Ottawa, Ontario K1G 4J8. E-mail <email>info@cps.ca</email>, website <ext-link ext-link-type="uri" xlink:href="http://www.cps.ca">www.cps.ca</ext-link></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-08-16" pub-type="epub">
<day>16</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>23</volume>
<issue>6</issue>
<fpage>403</fpage>
<lpage>410</lpage>
<permissions>
<copyright-statement>© Canadian Paediatric Society 2018. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="pxy093.pdf"></self-uri>
<related-article ext-link-type="doi" id="d35e103" related-article-type="alt-language" xlink:href="10.1093/pch/pxy099"></related-article>
<abstract>
<title>Abstract</title>
<p>Global developmental delay (GDD) and intellectual disability (ID) are common concerns in the paediatric setting. Etiologies of both conditions are highly heterogeneous. The American Academy of Pediatrics, the American Academy of Neurology and the British Columbia-based Treatable Intellectual Disability Endeavor (TIDE) protocol have each proposed multitiered investigations of GDD/ID to guide physicians toward an understanding of etiology that optimizes therapeutic yield. This statement provides a framework for the clinical investigation of GDD/ID in children, along with an updated protocol for Canadian physicians to follow in the etiological investigation of GDD/ID. The revised protocol is based on current knowledge and existing guidelines. Key elements of investigation include formal vision and hearing testing, chromosomal microarray, Fragile-X DNA testing and first-tier testing for treatable inborn errors of metabolism. Brain imaging is recommended in the presence of specific neurological findings.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Chromosome microarray</italic>
</kwd>
<kwd>
<italic>Global developmental delay</italic>
</kwd>
<kwd>
<italic>Intellectual disability</italic>
</kwd>
<kwd>
<italic>IEM</italic>
</kwd>
</kwd-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>